Effects of Riboflavin on Faecalibacterium Prausnitzii and the Gut Microbiota
Clinical trial NCT02929459 · COMPLETED
Trial details
- NCT number
- NCT02929459
- Sponsor
- dsm-firmenich Switzerland AG
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-11-01
- Primary completion
- 2018-10-01
- Enrollment
- 105
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.